SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo

SeraCare Life Sciences (Milford, MA, USA) promoted its new AccuSpan HCV RNA Linearity Panel at the 70th AACC Annual Scientific Meeting and Clinical Lab Expo held in Chicago, USA from July 29 - August 2.

SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. The company supports the diagnostic testing industry with biological materials to develop, validate, and challenge today's most trusted serology and molecular infectious disease assays. With recent rapid advances in clinical genomics and precision diagnostics, SeraCare has developed a leading portfolio of highly flexible, patient-like reference materials and lab QC programs to support advanced diagnostic applications such as next-generation sequencing and digital PCR.


At AACC 2018, SeraCare promoted its new AccuSpan HCV RNA Linearity Panel, a safe, non-infectious panel that is compatible with leading PCR-based applications and features eight members in K3EDTA plasma. The eight-member panel is made from serial dilutions of high titer recombinant Hepatitis C virus (genotype 1b) with established reactivity for HCV RNA and one negative member. The panel consists of seven members representing serial log dilutions of AccuPlex recombinant HCV in negative diluent and one negative member prepared from the diluent. The diluent was prepared from pooled K3EDTA plasma that was filtered through a 0.2 micron filter with sodium azide (0.09%) added as a preservative.

The panel can be used for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, verifying lot changes, performing linearity studies, or whenever there are indications of possible assay deterioration.

Related Links:
SeraCare Life Sciences